Advertisement

Topics

Search Results for "Genital Squamous Cell Carinoma"

12:36 EDT 26th July 2017 | BioPortfolio

Matching Channels

Squamous Cell Carcinoma

Squamous cell carcinoma (SCC) is a carcinomatous cancer occurring in many different organs, including the skin, lips, mouth, esophagus, urinary bladder, prostate, lungs, vagina, and cervix. It is a ...

Oral Squamous Cell Carcinoma

CIN and squamous cell carcinoma stage IA1

Squamous cell cancer of the anus and vulva

Genital

Matching News

Cutaneous Squamous cell Carcinoma CsCC Epidemiology Insights to 2025 [Report Updated: 10072017] Prices from USD $2950

DelveInsight Cutaneous Squamous cell Carcinoma CsCC Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Cutaneous Squamous cell Carcinoma CsCC in seven major markets US,...

Cutaneous Squamous cell Carcinoma CsCC Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10072017] Prices from USD $5750

DelveInsight's Cutaneous Squamous cell Carcinoma CsCC Market Insights, Epidemiology and Market Forecast 2025 Reports provides an overview of the disease and global market size of the Cutaneous Squam...

Immunotherapy Safely Treats Advanced Squamous Cell Carcinoma

An anti–PD-1 monoclonal antibody is safe and effective for patients with unresectable, locally advanced, or metastatic cutaneous squamous cell carcinoma.

Cutaneous Squamous cell CarcinomaMarket Insights, Epidemiology and Market Forecast2023 [Updated: 30052017] Prices from USD $4208

DelveInsight's Cutaneous Squamous Cell Carcinoma cSCC Market Insights, Epidemiology and Market Forecast20237MM report provides an overview of the disease and global market size of the Cutaneous Squamo...

Nivolumab Maintained QOL in Advanced Squamous Cell Head and Neck Cancer

Patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with the checkpoint inhibitor nivolumab were able to maintain baseline levels of quality of life.

Perineural Invasion Ups Mortality Risk in Squamous Cell Skin CA

Patients with cutaneous squamous cell carcinoma (CSCC) and perineural invasion (PNI) are at increased risk of death, particularly when PNI is identified clinically or radiologically and not only micro...

[Comment] HPV-related oropharyngeal carcinoma de-escalation protocols

Human papillomavirus (HPV) is now recognised as the principal cause of the increasing incidence of oropharyngeal squamous-cell carcinoma in developed countries. HPV-related oropharyngeal squamous-cell...

[Articles] Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial

Nivolumab showed promising activity with a manageable safety profile. This drug could offer a potential new treatment approach for patients with treatment-refractory advanced squamous-cell carcinoma.

Matching PubMed Articles

Meta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers.

Non-small cell lung cancer (NSCLC) consists of several subtypes, including adenocarcinoma, squamous cell lung cancer, large cell lung cancer, and other rarer types. Platinum-based regimens are current...

Sarcomatoid Squamous Cell Carcinoma of the Penis - a Report of Two Cases.

Sarcomatoid (spindle cell) squamous cell carcinoma is a rare, highgrade, aggressive tumor consisting of the squamous cell carcinoma admixed with the malignant spindle cell (sarcomatoid) elements. Thes...

miR-183 Modulates Cell Apoptosis and Proliferation in Tongue Squamous Cell Carcinoma SCC25 Cell Line.

This study was designed to investigate the role of miR-183 in modulating cell growth and apoptosis of tongue squamous cell carcinoma SCC25 cell line. Human squamous epithelial cell and squamous cell c...

Frequency of Squamous Cell Carcinoma In Situ and Squamous Cell Carcinoma in Re-Excisions of Biopsy-Proven Cutaneous Squamous Cell Carcinoma In Situ.

Multiple surgical and nonsurgical treatments for cutaneous squamous cell carcinoma in situ (SCCIS), sometimes called Bowen's disease, have been described. The best treatment option has not yet been de...

Tyrosine kinase inhibitor TKI-258 inhibts cell motility in oral squamous cell carcinoma in vitro.

Oral squamous cell carcinoma is extremely invasive, this behavior is regulated by binding of extracellular molecules to the cell membrane receptors. The TKI-258 inhibits phosphorylation of FGFRs VEGFR...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement